GSK3B and hepatocellular carcinoma: Several studies have shown that SMYD3 can interact with the HBV-HBx protein, which can induce upregulation of SMYD3 in HCC, these interactions promote the development of HCC by regulating ERK- and AKT/GSK-3β signaling pathways17–19,35.